Trial intelligence / Profile preview

Intravenous atropine for prevention of post-spinal hypotension and bradycardia during cesarean section

IRCT20120915010841N18Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
May 2019
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypotension and bradyarrhythmia comparing Atropine with Placebo (2 arms). Primary endpoints: Hypotension and Bradycardia. Started May 2019; status: completed.

02

Drugs

atropine
03

Conditions

hypotensionbradyarrhythmia

Beyond the preview

Go deeper on IRCT20120915010841N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120915010841N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call